analytical characterisation is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-01-20. Numbers and descriptions here follow the published literature rather than marketing material.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Unapproved for therapeutic use | No marketing authorisation from major agencies |
| Legal classification | Varies by jurisdiction | Prescription-only or controlled in several countries |
| Common synonyms | Melanotan II; MT-II | Also referenced by catalogue codes |
| Typical analytical method | Reverse-phase HPLC | Often paired with mass spectrometry |
| Primary literature focus | Receptor pharmacology | Pigmentation and melanocortin signalling |
Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
The presence of Sialyl-Lewisx antigen (cluster of differentiation 15s (CD15s)), which is a fucosylated glycan, on the outer cell membrane, correlates with invasion potential of malignant cells, tumor recurrence, and overall patient survival for an extremely wide range of cancers. Expression of the Vim2 antigen, which is another SeV cell entry receptor represented by fucosylated glycan, is very important for the extravascular infiltration process of acute myeloid leukemia cells. Metastatic cancer cells often are coated with glycolipids that are rich in sialic acids. SeV binds to α2,3-linked sialic acid containing glycolipids. For example, GD1a, which is a ganglioside and sialylated glycan (glycolipid), is found in large quantities on the surfaces of breast cancer stem cells. High cell surface expression of another SeV receptor – ganglioside sialosylparagloboside /SPG/ NeuAcα2-3PG. characterizes lymphoid leukemia cells. Among other receptors represented by gangliosides GT1b is highly expressed on the outer membranes of cells of brain metastases that originate from an extremely broad range of cancer, while GD1a, GT1b and GQ1b can be detected in human gliosarcomas. However, their quantity does not exceeded the quantity in normal frontal cerebral cortex.
Lattice models (e.g. BIO-LGCA models) Models similar to Dissipative particle dynamics that solve Newton's equation of motion with dissipative and random forces Models where cells depict Voronoi regions and an effective potential (based on Voronoi graphs) for the tissue is used Continuum models, e.g. with the use of a phase field Kinetic theories similar to the Boltzmann equation These mathematical models give some insight in complex phenomena like cancer, wound healing and ectoplasms.
Nitro blue tetrazolium is used in a diagnostic test, in particular, for chronic granulomatous disease, a disease in which there is a defect in NADPH oxidase; therefore, the phagocyte is unable to make the reactive oxygen species or radicals required for bacterial killing, resulting in bacteria thriving within the phagocyte. The higher the blue score the better the cell is at producing reactive oxygen species. It has also been shown that NADPH oxidase plays a role in the mechanism that induces the formation of sFlt-1, a protein that deactivates certain proangiogenic factors that play a role in the development of the placenta, by facilitating the formation of reactive oxygen species, which are suspected intermediaries in sFlt-1 formation. These effects are in part responsible for inducing pre-eclampsia in pregnant women
Sources: en.wikipedia.org
9 February – Donald Cameron, a Conservative list MSP for the Highlands and Islands, announces he is standing down from the Scottish Parliament to take up a seat in the House of Lords and a junior ministerial post in the Scottish Office. 10 February – Police Scotland are investigating 22 deaths that occurred at the Fullarton Care Home in Irvine, North Ayrshire during the COVID-19 pandemic. The home was one of the worst affected during the early days of the pandemic. 11 February – Canadian woman Claire Leveque, aged 24, dies following a disturbance in Sandness, Shetland. Aren Pearson is subsequently charged with her murder. 12 February – Actor and writer Simon Fanshawe is named the new Rector of the University of Edinburgh, succeeding Debora Kayembe. A man is arrested and charged over several acts of vandalism in Glasgow, including graffiti relating to the Gaza conflict daubed on the city's cenotaph. 13 February – Former NHS worker Tracy Menhinick, who gave a young boy "industrial amounts" of the laxative lactulose, is found guilty of poisoning the child following a 19-day trial at the High Court in Aberdeen. 14 February – Jordan Mitchell, who spoke about his desire to commit mass murder in Falkirk during a hospital visit, and who said he had killed animals, is given an Order for Lifelong Restriction by the Court of Criminal Appeal. 15 February – Glasgow City Council and North Lanarkshire Council vote to freeze council tax for the 2024–25 financial year.
== Contraindications == Contraindications of anastrozole include hypersensitivity to anastrozole or any other component of anastrozole formulations, pregnancy, and breastfeeding. Hypersensitivity reactions to anastrozole including anaphylaxis, angioedema, and urticaria have been observed.
Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, for early puberty, as part of transgender hormone therapy, or to perform chemical castration of violent sex offenders. It is given by injection into a muscle or under the skin. Leuprorelin is in the gonadotropin-releasing hormone (GnRH) analogue family of medications. It works by decreasing gonadotropins, thereby decreasing testosterone and estradiol. Common side effects include hot flashes, unstable mood, trouble sleeping, headaches, and pain at the site of injection. Other side effects may include high blood sugar, allergic reactions, and problems with the pituitary gland. Use during pregnancy may harm foetal development. Leuprorelin was patented in 1973 and approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines. It is sold under the brand name Lupron, among others.
== Treatment == Currently, there are no treatments for any of the congenital myopathies. Depending on the severity, there are different therapies available to help alleviate any pain and aid patients in performing varying activities. For example, many congenital myopathy patients are involved in physical or occupational therapy in an attempt to strengthen their skeletal muscles. Orthopedic surgery is usually necessary to correct skeletal deformities secondary to muscle weakness, such as scoliosis. Survival is typically determined by the level of respiratory muscle insufficiency.
Sources: en.wikipedia.org
==== Lung cancer ==== A prospective clinical study (NCT05835570) involving 58 participants with non-small cell lung cancer (NSCLC) compared the diagnostic performance of 68Ga-Trivehexin PET/CT with 18F-FDG PET/CT. Both radiotracers showed similar diagnostic accuracy (100%, 58/58) for the detection of primary tumors. The sensitivity for detection of lymph node metastases was comparable for 68Ga-Trivehexin (80%) and 18F-FDG (72%), but 68Ga-Trivehexin showed a higher specificity (93.8%) and accuracy (91.2%) than 18F-FDG (62.5% and 64.2%, respectively). Sensitivity for detecting brain metastasis was 92.3% for 68Ga-Trivehexin and 38.5% for 18F-FDG, mainly because of the high glucose consumption of normal brain tissue, which usually results in a high physiological uptake of 18F-FDG in the brain, generating a strong background signal which frequently obscures brain metastases in PET images (see image). Application of 68Ga-Trivehexin PET was reported for single cases of other, rare forms of lung cancer, such as bronchial mucoepidermoid carcinoma and mucinous lung adenocarcinoma.
HLA-DM (human leukocyte antigen DM) is an intracellular protein involved in the mechanism of antigen presentation on antigen presenting cells (APCs) of the immune system. It does this by assisting in peptide loading of major histocompatibility complex (MHC) class II membrane-bound proteins. HLA-DM is encoded by the genes HLA-DMA and HLA-DMB. HLA-DM is a molecular chaperone that works in lysosomes and endosomes in cells of the immune system. It works in APCs like macrophages, dendritic cells, and B cells by interacting with MHC class II molecules. HLA-DM protects the MHC class II molecules from breaking down, and regulates which proteins or peptides bind to them as well. This regulates how and when a peptide acts as an antigen initiating an immune response. Thus, HLA-DM is necessary for the immune system to respond effectively to a foreign invader. Impairment in HLA-DM function can result in immunodeficiency and autoimmune diseases.
Portugal's territory comprises mainland Portugal and the Azores and Madeira archipelagos. The mainland, commonly referred to as Continental Portugal, is located in the southwest of the Iberian Peninsula in Southwestern Europe, while Madeira and the Azores lie in the Atlantic Ocean. Portugal's land area is 92,225 km2 (35,608 sq mi), although Portuguese law defines the country's size as 156,597 km2 (60,462 sq mi) which includes about 64,000 km2 (24,711 sq mi) of ocean waters. Portugal's exclusive economic zone extends 1,727,408 km2 (666,956 mi2), making it one of the largest in the European Union. The country is over two-thirds wilderness, almost one-fourth agricultural, and the remainder human settlements. Portugal's highest point is the summit of Mount Pico, located on Pico Island in the Azores, which rises to an elevation of 2,351 m (7,713 ft) above sea level. Portugal can be divided into four morphostructural units: the Hesperian Massif, which occupies most of mainland Portugal; the sedimentary borderlands of the massif, forming the Lusitanian and Algarve basins; the Lower Tagus and Alvalade sedimentary basins; and the volcanic submarine ranges that form the Azores and Madeira. Its geological and geomorphological features are largely the product of the Variscan, responsible for the formation of the Hesperian Massif, and later the Tethys–Atlantic cycle, responsible for the remaining units.
Sources: en.wikipedia.org
Major regulatory agencies have not approved it for any indication. Some countries permit it only under prescription frameworks, while others classify it as a controlled substance.
Much of the evidence comes from case reports and accounts of unregulated use rather than controlled trials. Differences in product purity and dosing add further variability.
Laboratory work focuses on receptor binding and cellular signalling. Observational reports document outcomes after use, and analytical chemists examine samples to assess content and purity.
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.